Skip to main content

Table 2 Study population characteristics at follow-up

From: Sex difference in clot lysability and association to coronary artery calcification

Follow-up, N = 163

Men (n = 79)

Women (n = 84)

p value

Born

 1949 (n = 70)

30 (43)

40 (57)

 

 1959 (n = 93)

49 (53)

44 (47)

0.21

Tobacco use

 Never (n = 76)

34 (45)

42 (55)

 

 Prior/current (n = 87)

45 (52)

42 (48)

0.47

Systolic blood pressure, mmHg

Diastolic blood pressure, mmHg

140 (17)

81 (8)

133 (16)

72 (9)

0.013

< 0.001

Body mass index, kg/m2

28.1 (4.2)

26.9 (4.7)

0.063

Agatston score, U

9 (0–115)

0 (0–26)

0.002

ΔAgatston score, U

4 (0–49)

0 (0–10)

0.012

Total cholesterol, mmol/l

LDL cholesterol, mmol/l

HDL cholesterol, mmol/l

Triglycerides, mmol/l

5.31 (0.85)

3.33 (0.80)

1.30 (1.10–1.40)

1.82 (0.97)

5.54 (0.92)

3.30 (0.93)

1.55 (1.40–1.75)

1.50 (0.89)

0.10

0.80

< 0.001

0.032

C-reactive protein, mg/l

0.74 (0.46–1.61)

0.70 (0.30–2.18)

0.74

Fibrinogen, μmol/l

8.9 (7.7–10.3)

9.5 (8.4–11.1)

0.056

PAI-1, ng/ml

21.7 (15.4–27.5)

20.1 (15.0–30.3)

0.69

Fibrin clot lysability, %

52.1 (20.5)

47.2 (22.3)

0.14

  1. Values are presented as mean (SD), median (IQR), or number (%). Information on Agatston score is missing on one participant
  2. LDL low-density lipoprotein, HDL high-density lipoprotein, PAI-1 plasminogen activator inhibitor type 1